TX-PLANVIEW
Planview, a global leader in Portfolio Management and Work Management solutions, today published a global report that unlocks how companies are successfully responding to continuous market disruption, accelerating innovation and executing on their business strategies. Based on a first-of-its-kind study, the report, titled “The State of Strategy Execution: Embracing Uncertainty to Adapt at Speed ,” uncovers why many companies are challenged to pivot strategy in times of change, and provides pragmatic recommendations for companies to adapt more quickly to shifting conditions and disruptive events, and deliver quality business outcomes.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210324005214/en/
“This study was designed to answer a deceptively simple question: Why can some companies quickly adapt and even accelerate strategy execution during times of significant change, and others just get by?,” said Patrick Tickle, Chief Product Officer at Planview. “That question is of utmost importance not only today while we navigate the pandemic but for the foreseeable future. Market disruptions are no longer the exception. Disruption is the norm, and the smartest companies have learned how to not just survive but thrive in environments of constant change.”
Segmenting respondents into categories of Leaders, Challengers and Laggards, a clear picture emerged of what successful companies are doing and that others can replicate, including:
- Prioritizing speed when it comes to making decisions and executing faster
- Implementing technology that delivers faster business insights from data
- Adjusting strategies, funding, and operating plans with short-interval planning cycles
- Improving the prioritization process to realign resources to the most important work
- Utilizing Lean and Agile business practices throughout the organization
This vital report goes beyond just analyzing why some organizations are more successful than others in quickly adapting to market disruptions. It provides a roadmap for how other companies can achieve success, streamline business processes to prioritize speed and quality, accelerate innovation, and improve strategic outcomes.
“Reducing the gap between strategy and execution becomes even more important as the pace of external disruption increases, and this report provides a clear blueprint about how leading companies are doing exactly that,” said Tickle. “We found that the most successful companies are following a similar recipe for success. They are building speed into their business operations to adjust to constant change. They have shorter, more adaptable planning cycles that enable them to respond to shifts in real-time. They remove internal barriers that stand in the way of adaptability. They resist the lure of the status quo. And they use technology and agile processes to build speed and quality into the way they execute on strategy.”
Based on a global benchmarking analysis of nearly 1,000 business and technology professionals at organizations across a wide range of industries around the world, the survey was commissioned by Planview and conducted by independent research firm Lawless Research. Results uncovered why many companies struggle to quickly respond to change and disruption:
- Complex governance or approval processes (38%)
- Unclear or conflicting priorities (33%)
- Lack of resources to complete all approved projects (31%)
- Lack of organizational alignment (departmental silos) (31%)
To read the full report and its detailed set of recommendations, visit: The State of Strategy Execution: Embracing Uncertainty to Adapt at Speed . To get more insights into the best practices utilized by many of the successful companies in the benchmarking study, visit: Managing Transformation: Connect Strategy to Delivery to Dynamic Business Today .
Survey Methodology
Planview commissioned a survey, undertaken by an independent research organization, Lawless Research, in December 2020. Nearly 1,000 business and technology professionals across multiple countries were surveyed, including: Australia, France, Germany, United States, and the UK. Companies were from a range of industries, including banking and financial, technology, retail, manufacturing, healthcare, business services, government and public sector, travel and hospitality, engineering, and more. The corresponding report provides pragmatic recommendations for business, technology, and finance leaders seeking to create a tight connection between strategy and execution, adapt more quickly to shifting conditions and disruptive events, and deliver quality business outcomes.
About Planview
Planview has one focus: enabling the transformation journey as organizations rewire strategy to delivery in today’s fast-paced, highly disruptive markets. Our solutions enable organizations to navigate this journey and accelerate on-strategy delivery at enterprise scale. Planview’s full spectrum of Portfolio Management and Work Management solutions create organizational focus on the strategic outcomes that matter and empower teams to deliver their best work, no matter how they work. The comprehensive Planview platform and enterprise success model enable customers to deliver innovative, competitive products, services, and customer experiences. Headquartered in Austin, Texas, Planview has more than 1,000 employees supporting 4,500 customers and 1.3 million users worldwide. For more information, visit: www.planview.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20210324005214/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Opens up New Chapter for Sculptra® with MDR Certification and New Expanded Indication for Body5.12.2025 07:00:00 CET | Press release
Sculptra®, the first proven regenerative biostimulator, has received European Union (EU) Medical Device Regulation (MDR) certification, expanding its current clinical application for the face to include gluteal area, posterior thighs, décolletage, and upper arms1 Studies investigating the efficacy of Sculptra on areas beyond the face show patients experienced progressive improvements in skin quality (including the improvement in cellulite appearance), firmness, lift, projection, and contour Sculptra’s versatility and new indication allow practitioners to shift patient treatment goals beyond rejuvenation toward enhancement, meeting evolving patient needs The certification validates Sculptra’s safety performance, efficacy, and quality, reinforcing Galderma’s commitment to innovation and meeting evolving patient needs Galderma (SIX: GALD), the pure-play dermatology category leader, today announced the certification of Sculptra for body indications in the European Union (EU) following its
Northern Escape Heli-Skiing Takes the Title of “World’s Best Heli-Ski-Operator” for the 4th Year Running5.12.2025 02:40:00 CET | Press release
4x World’s Best Heli-Skiing Operation near Terrace, BC Northern Escape Heli-Skiing (NEH) has been named World’s Best Heli-Ski Operator 2025 by the World Ski Awards, marking its fourth straight victory following years 2022, 2023 and 2024. This recognition places NEH amongst an elite group of ski tourism operators consistently voted best in the world by industry leaders and enthusiasts alike. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251204074550/en/ A four-year run built on reliability NEH operates in British Columbia’s Skeena Mountains, where deep northern snow and vast terrain come together with small-group heli-skiing and heli snowboarding. When helicopters can’t safely fly, NEH has cat skiing readily available as a backup — an exceedingly rare offering in this industry. The operation spans over 833,571 wild acres of alpine bowls, glaciers and old-growth tree skiing. The NEH experience Guests choose from three lodge f
IDE034, a Bispecific ADC Licensed by Biocytogen to IDEAYA, Receives FDA IND Clearance5.12.2025 01:00:00 CET | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, HKEX: 02315), announced that its partner IDEAYA Biosciences, Inc. (Nasdaq: IDYA), a precision oncology company, has received the clearance of an investigational new drug (IND) application with the U.S. Food and Drug Administration (FDA) for the initiation of a Phase 1 clinical trial of IDE034, a potential first-in-class B7H3/PTK7 bispecific antibody-drug conjugate (ADC). IDEAYA expects to begin patient enrollment in Q1 2026, initially evaluating patients with solid tumors known to express B7H3 and PTK7, including lung, colorectal, head and neck, and ovarian/gynecological cancers. IDE034 is a bispecific B7H3/PTK7 TOP1 ADC, independently developed by Biocytogen and licensed to IDEAYA in July 2024. The IND clearance marks an important milestone for this licensed program, supporting subsequent clinical development of IDE034, while highlighting Biocytogen’s technical capabilities in bispecific ADC discovery and development. Dr. Yue
Helical Fusion, Developer of Next-Generation Clean Energy Through Nuclear Fusion, Completes USD 5.5M Series A Extension Round5.12.2025 01:00:00 CET | Press release
Stakeholder base expands with participation from an individual-investor-oriented fund, alongside corporate and individual investors, bringing Total Funding to USD 38M Helical Fusion Co., Ltd. (Head Office: Chuo-ku, Tokyo; CEO: Takaya Taguchi; hereafter “Helical Fusion”), which is developing a next-generation energy source using Japan’s original Helical Stellarator technology to realize commercially viable fusion power plant in the 2030s, announced the completion of its Series A Extension round, raising approximately USD 5.5 million (≈ JPY 870 million). The round included investments from “Ecrowd NEXT”, a fund designed for individual investors, as well as multiple corporate investors and individual investors. As a result, Helical Fusion’s total Series A funding, including loans, amounts to approximately USD 21 million (≈ JPY 3.2 billion), bringing the company’s cumulative fundraising—including grants and loans—to approximately USD 38 million (≈ JPY 6.0 billion). With this funding, Helic
Andersen Consulting udvider sin tilstedeværelse gennem samarbejde med Hilal Technology4.12.2025 23:04:00 CET | Pressemeddelelse
Andersen Consulting indgår en samarbejdsaftale med Hilal Technology for at styrke sine kompetencer inden for digital infrastruktur, cybersikkerhed og AI. Med tilstedeværelse i Bahrain, Saudi-Arabien, De Forenede Arabiske Emirater, Oman og Indien leverer Hilal Technology et komplet spektrum af digital infrastruktur og managed services inden for cloudcomputing, cybersikkerhed, enterprise ai og systemintegration. Deres ydelser omfatter cloudtjenester, sikkerheds- og netværksdrift, implementering af ERP og applikationer samt udvikling af generative ai-kapaciteter. Med et team på mere end 250 fagfolk servicerer firmaet en bred vifte af brancher, herunder den finansielle sektor, olie og gas, logistik og den offentlige sektor. "Transformation er mere end systemer; det handler om parathed, tillid og løbende samarbejde," udtaler Roshan George, direktør for Hilal Technology. "Vi er begejstrede for at samarbejde med Andersen Consulting og levere skalerbare løsninger, der matcher tempoet i den dig
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
